These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 232665)

  • 21. Rapid purification of Bordetella pertussis toxin by alternating affinity and hydrophobic chromatography.
    Svoboda M; Hannecart-Pokorni E; Borremans M; Christophe J
    Anal Biochem; 1986 Dec; 159(2):402-11. PubMed ID: 3826625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis.
    Arai H; Sato Y
    Biochim Biophys Acta; 1976 Oct; 444(3):765-82. PubMed ID: 186106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against intranasal infection of mice with Bordetella pertussis.
    Robinson A; Ashworth LA; Baskerville A; Irons LI
    Dev Biol Stand; 1985; 61():165-72. PubMed ID: 2872102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of cyclodextrin on lipopolysaccharide production in cultures of Bordetella pertussis.
    Ibsen P; Schou C; Au-Jensen M; Heron I
    J Biol Stand; 1989 Oct; 17(4):321-30. PubMed ID: 2559082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification of pertussis toxin.
    Perera VY
    Methods Enzymol; 1988; 165():120-6. PubMed ID: 2906727
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of Bordetella pertussis lymphocytosis-promoting factor (LPF) on antibody response in mice: its enhancing and suppressive effects.
    Asakawa S; Iwasa S
    Jpn J Med Sci Biol; 1982 Feb; 35(1):25-9. PubMed ID: 6285047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular aspects of Bordetella pertussis pathogenesis.
    Locht C
    Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin.
    Halperin SA; Issekutz TB; Kasina A
    J Infect Dis; 1991 Feb; 163(2):355-61. PubMed ID: 1703192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell surface antigens of Bordetella pertussis.
    Parker CD; Branes LV; Armstrong SK; Frank DW; Cole A
    Dev Biol Stand; 1985; 61():123-36. PubMed ID: 2872098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production and purification of Bordetella pertussis toxin.
    Ju CL; Sheu GC; Cheng Y; Lu CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 May; 30(2):72-83. PubMed ID: 10592813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human T gamma and non-T gamma cells.
    Kashiwa H; Hyodo S; Kishi T; Karakawa T; Kittaka E; Suzawa T; Sakano T; Usui T
    Clin Exp Immunol; 1984 Nov; 58(2):436-43. PubMed ID: 6094059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.
    Weiss AA; Hewlett EL; Myers GA; Falkow S
    J Infect Dis; 1984 Aug; 150(2):219-22. PubMed ID: 6088647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bordetella pertussis tracheal cytotoxin.
    Goldman WE; Herwaldt LA
    Dev Biol Stand; 1985; 61():103-11. PubMed ID: 2872096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapidity of antigenic modulation of Bordetella pertussis in modified Hornibrook medium.
    Idigbe EO; Parton R; Wardlaw AC
    J Med Microbiol; 1981 Nov; 14(4):409-18. PubMed ID: 6273564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphonuclear leukocyte-inhibitory factor of Bordetella pertussis. II. Localization in the outer membrane.
    Imagawa T; Sonoda S; Kanoh M; Utsumi S
    Biken J; 1979 Mar; 22(1):1-10. PubMed ID: 43725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant of Bordetella pertussis which lacks ability to produce filamentous hemagglutinin.
    Watanabe M; Nakase Y
    Infect Immun; 1982 Mar; 35(3):1018-23. PubMed ID: 6279510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific anti-Bordetella pertussis activities in human blood examined by enzyme-linked immunoassay and biological assay.
    Marley PB; Wilson JV; Habel H; Blaskett A
    Dev Biol Stand; 1985; 61():341-52. PubMed ID: 2872123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel bivalent acellular pertussis vaccine based on the 69 kDa protein and FHA.
    Novotny P; Chubb AP; Cownley K; Charles IG
    Dev Biol Stand; 1991; 73():243-9. PubMed ID: 1778316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin.
    Menozzi FD; Gantiez C; Locht C
    FEMS Microbiol Lett; 1991 Feb; 78(1):59-64. PubMed ID: 2032624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.